Laboratorios Farma | ROVI - Ebitda

股票价格

81.30

每天变化

0.20 0.25%

每月一次

1.88%

每年

58.79%

Q2 预测

79.04

金融业

EUR

EUR 799.88M

现金及等价物

EUR 46.11M

EUR 186.09M

EUR 509.33M

EUR 199.84M

EUR 129.3M

股息收益率

2.15

EUR 135.05M

EUR 34.94M

1.99K

EPS每股收益

EUR 1.96

股本和储备

EUR 539.39M

EUR 105.28M

债务利息支出

EUR 699K

EUR 139K

EUR 80.5M

EUR 4.18B

EUR 103.69M

EUR 313.62M

EUR 135.05M

普通股股本

EUR 51.82M

18.78

EUR 26.78M

EUR 448.66M

销售和管理费用

EUR 35.32M

EUR 327.67M

贸易债权人

EUR 107.59M

应收帐款人

EUR 143.38M

	Ebitda	更改		日
Akebia Therapeutics	USD 14.03M		17.19M	2025-03
Alaunos Therapeutics	USD -21.02M		1.33M	2021-03
Almirall	EUR 114.07M		60.37M	2025-12
Avita Medical	AUD -9.69M		12.21M	2025-12
Dianthus Therapeutics	USD -40.19M		5.36M	2025-09
Ionis Pharmaceuticals	USD -157.12M		307.36M	2025-09
IQVIA Holdings	USD 1.05B		97M	2025-12
Laboratorios Farma	EUR 34.94M		102.95M	2025-06
Moderna	USD -790M		582M	2025-12
Organon & Co	USD 383M		135M	2025-12
Pharma Mar	EUR 44.96M		46.94M	2025-12
Revvity	USD 248.91M		48.52M	2025-12
Tectonic Therapeutic	USD -21.18M		365K	2025-12
Viatris	USD 1B		151.5M	2025-12
Xeris Pharmaceuticals	USD 25.09M		7.67M	2025-12